UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Cyclophosphamide and Thiotepa Increases Risk of Transplant-Associated Thrombotic Microangiopathy

Transplantation and cellular therapy, 2024-06

2024

Volltextzugriff (PDF)

An Unusual Presentation of Kaposiform Hemangioendothelioma in the Mandibular Bone

Blood, 2021-11, Vol.138 (Supplement 1), p.4205-4205

2021

Volltextzugriff (PDF)

A Pilot Trial of Pre-Transplant Risk Stratification and Prophylactic Defibrotide to Prevent Serious Thrombotic Microangiopathy in High-Risk Pediatric Hematopoietic Stem Cell Transplant Patients

Blood, 2020-11, Vol.136 (Supplement 1), p.9-10

2020

Volltextzugriff (PDF)

Angiographic Evidence of Response to Trametinib Therapy for a Spinal Cord Arteriovenous Malformation

Journal of vascular anomalies (Philadelphia, Pa.), 2021-07, Vol.2 (3), p.e018

2021

Volltextzugriff (PDF)

Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell Transplants

Blood, 2019-11, Vol.134 (Supplement_1), p.4481-4481

2019

Volltextzugriff (PDF)

A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children

Blood, 2019-11, Vol.134 (Supplement_1), p.2369-2369

2019

Volltextzugriff (PDF)

Role of Disease Mechanism in Hematopoietic Cell Transplantation Outcomes for Hemophagocytic Lymphohistiocytosis

Blood, 2019-11, Vol.134 (Supplement_1), p.3343-3343

2019

Volltextzugriff (PDF)

Correlation of Minimal Residual Disease (MRD) at the End of Induction (EOI) and Event Free Survival (EFS) in T-Cell Lymphoblastic Lymphoma (T-LL), a Report from the Children's Oncology Group (COG) Trial AALL1231

Blood, 2022-11, Vol.140 (Supplement 1), p.6387-6389

2022

Volltextzugriff (PDF)

Autoimmune Cytopenias in Pediatric Hematopoietic Cell Transplant (HCT) Patients

Biology of blood and marrow transplantation, 2016-03, Vol.22 (3), p.S255-S255

2016

Volltextzugriff (PDF)

172 - Diagnosing and Grading of SOS: Which Criteria Are Best?

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S138-S139

2023

Volltextzugriff (PDF)

Diagnosing and Grading of SOS: Which Criteria Are Best?

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S138-S139

2023

Volltextzugriff (PDF)

Cranial Radiation Can be Eliminated in Most Children with T-Cell Acute Lymphoblastic Leukemia (T-ALL) and Bortezomib Potentially Improves Survival in Children with T-Cell Lymphoblastic Lymphoma (T-LL): Results of Children's Oncology Group (COG) Trial AALL1231

Blood, 2020-11, Vol.136 (Supplement 1), p.11-12

2020

Volltextzugriff (PDF)

Prophylactic Tocilizumab Decreases Incidence of Acute Graft-Versus-Host Disease Following Alpha/Beta T-Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation in Children and Young Adults

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S263-S264

2023

Volltextzugriff (PDF)

345 - Prophylactic Tocilizumab Decreases Incidence of Acute Graft-Versus-Host Disease Following Alpha/Beta T-Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation in Children and Young Adults

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S263-S264

2023

Volltextzugriff (PDF)

The Impact of Total Body Irradiation-Based Regimens on Outcomes in Children and Young Adults with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Biology of blood and marrow transplantation, 2019-03, Vol.25 (3), p.S197-S198

2019

Volltextzugriff (PDF)

169 Long Term Management of Transplanted Patients with Chronic Granulomatous Disease, Wiskott-Aldrich Syndrome, and Primary Immune Regulatory Disorders: A PIDTC Survey

Clinical immunology (Orlando, Fla.), 2024-05, Vol.262, p.110111, Article 110111

2024

Volltextzugriff (PDF)

13 Long-Term Medical Management of Patients with Chronic Granulomatous Disease, Wiskott-Aldrich Syndrome, and Primary Immune Regulatory Disorders: A Primary Immune Deficiency Treatment Consortium Survey

Clinical immunology (Orlando, Fla.), 2024-05, Vol.262, p.109955, Article 109955

2024

Volltextzugriff (PDF)

Daratumumab Is Effective in the Treatment of Refractory Post-Transplant Autoimmune Hemolytic Anemia: A Pediatric Case Report

Blood, 2016-12, Vol.128 (22), p.4819-4819

2016

Volltextzugriff (PDF)

JAK/STAT Pathway Inhibition Reverts IL7-Induced Glucocorticoid Resistance in a Subset of Human T-Cell Acute Lymphoblastic Leukemia

Blood, 2016-12, Vol.128 (22), p.3963-3963

2016

Volltextzugriff (PDF)

Physician Factors Determining Treatment Decisions in Selecting Second Line Agents for Pediatric ITP

Blood, 2016-12, Vol.128 (22), p.1008-1008

2016

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(27)
Buchkapitel
(2)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Blood
(15)
Transplantation And Cellular Therapy
(5)
Biology Of Blood And Marrow Transplantation
(2)
Clinical Immunology
(2)
Blood Advances
(1)
Journal Of Vascular Anomalies
(1)
Pediatric Blood & Cancer
(1)

2 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231

Cyclophosphamide and Thiotepa Increases Risk of Transplant-Associated Thrombotic Microangiopathy

An Unusual Presentation of Kaposiform Hemangioendothelioma in the Mandibular Bone

A Pilot Trial of Pre-Transplant Risk Stratification and Prophylactic Defibrotide to Prevent Serious Thrombotic Microangiopathy in High-Risk Pediatric Hematopoietic Stem Cell Transplant Patients

Angiographic Evidence of Response to Trametinib Therapy for a Spinal Cord Arteriovenous Malformation

Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell Transplants

A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children

Role of Disease Mechanism in Hematopoietic Cell Transplantation Outcomes for Hemophagocytic Lymphohistiocytosis

Correlation of Minimal Residual Disease (MRD) at the End of Induction (EOI) and Event Free Survival (EFS) in T-Cell Lymphoblastic Lymphoma (T-LL), a Report from the Children's Oncology Group (COG) Trial AALL1231

Autoimmune Cytopenias in Pediatric Hematopoietic Cell Transplant (HCT) Patients

172 - Diagnosing and Grading of SOS: Which Criteria Are Best?

Diagnosing and Grading of SOS: Which Criteria Are Best?

Cranial Radiation Can be Eliminated in Most Children with T-Cell Acute Lymphoblastic Leukemia (T-ALL) and Bortezomib Potentially Improves Survival in Children with T-Cell Lymphoblastic Lymphoma (T-LL): Results of Children's Oncology Group (COG) Trial AALL1231

Prophylactic Tocilizumab Decreases Incidence of Acute Graft-Versus-Host Disease Following Alpha/Beta T-Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation in Children and Young Adults

345 - Prophylactic Tocilizumab Decreases Incidence of Acute Graft-Versus-Host Disease Following Alpha/Beta T-Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation in Children and Young Adults

Health Related Quality of Life and Fatigue Improve on Second Line Treatments in Pediatric Immune Thrombocytopenia (ITP)

What's in a name: defining pediatric refractory ITP

The Impact of Total Body Irradiation-Based Regimens on Outcomes in Children and Young Adults with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

169 Long Term Management of Transplanted Patients with Chronic Granulomatous Disease, Wiskott-Aldrich Syndrome, and Primary Immune Regulatory Disorders: A PIDTC Survey

13 Long-Term Medical Management of Patients with Chronic Granulomatous Disease, Wiskott-Aldrich Syndrome, and Primary Immune Regulatory Disorders: A Primary Immune Deficiency Treatment Consortium Survey

Daratumumab Is Effective in the Treatment of Refractory Post-Transplant Autoimmune Hemolytic Anemia: A Pediatric Case Report

JAK/STAT Pathway Inhibition Reverts IL7-Induced Glucocorticoid Resistance in a Subset of Human T-Cell Acute Lymphoblastic Leukemia

Comparison of Bleeding Tools in a Cohort of Pediatric Patients with ITP: Data from the Pediatric ITP Consortium of North America ICON1 Study

Clinical Characteristics and Quality of Life of Children with ITP Starting Second Line Treatments: Data from the ITP Consortium of North America ICON1 Study

Physician Factors Determining Treatment Decisions in Selecting Second Line Agents for Pediatric ITP

Aktive Filter

Suchergebnisse filtern